ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,858Medicare Part D Prescriptions Filled, Including Refills

Rank: 197 out of 890

$768K Total Retail Price of All Prescriptions

Rank: 112 out of 890

559 Patients Receiving at Least One Drug in Part D
53%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

14% of this provider’s 559 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 6,427 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
AMLODIPINE BESYLATE 460 292 1 1
METFORMIN HCL 378 222 2 6
AMLODIPINE BESYLATE-BENAZEPRIL 241 173 3 41
OMEPRAZOLE 238 154 4 8
HYDROCODONE-ACETAMINOPHEN 230 147 S3 5 3
TRAMADOL HCL 228 157 6 16
PRAVASTATIN SODIUM 227 163 7 10
SIMVASTATIN 220 81 8 5
HYDROCHLOROTHIAZIDE 213 131 9 9
CLONIDINE HCL 205 109 10 35
LISINOPRIL 192 98 11 4
FUROSEMIDE 191 123 12 7
DIOVAN HCT 183 103 13 48
TAMSULOSIN HCL 181 81 14 32
POTASSIUM CHLORIDE 169 108 15 11
GABAPENTIN 167 110 16 12
LEVOTHYROXINE SODIUM 158 79 17 2
LISINOPRIL-HYDROCHLOROTHIAZIDE 146 58 18 21
CARVEDILOL 138 108 19 22
EXFORGE 133 108 20 140
FLUTICASONE PROPIONATE 126 91 21 39
BYSTOLIC 125 109 22 86
GLIMEPIRIDE 119 68 23 27
METOPROLOL TARTRATE 112 79 24 15
EXFORGE HCT 109 94 25 220
PROAIR HFA 106 70 26 55
RISPERIDONE 102 20 27 78
ATORVASTATIN CALCIUM 98 81 28 13
LOSARTAN-HYDROCHLOROTHIAZIDE 97 75 29 57
LOVASTATIN 97 71 29 46
CRESTOR 93 75 31 25
MELOXICAM 93 55 31 18
METOPROLOL SUCCINATE 87 68 33 17
LOSARTAN POTASSIUM 86 50 34 29
SULFAMETHOXAZOLE-TRIMETHOPRIM 85 51 35 76
GLIPIZIDE 81 59 36 62
JANUVIA 80 50 37 59
CYCLOBENZAPRINE HCL 77 17 R 38 64
FAMOTIDINE 77 27 38 90
CLOPIDOGREL 76 62 40 28
NAMENDA 73 43 41 36
TRAZODONE HCL 72 21 42 40
DEXILANT 72 40 42 138
ACTOS 68 45 44 88
LANTUS SOLOSTAR 67 43 45 102
DIOVAN 65 46 46 33
LYRICA 64 33 47 71
CELEBREX 64 39 47 91
NEXIUM 63 34 49 14
ESCITALOPRAM OXALATE 62 31 50 51
AMITRIPTYLINE HCL 62 19 R 50 43
OLANZAPINE 61 0 52 145
PANTOPRAZOLE SODIUM 61 35 52 34
ALLOPURINOL 60 40 54 31
COLCRYS 60 49 54 150
ADVAIR DISKUS 58 43 56 52
ATENOLOL 57 35 57 23
DICLOFENAC SODIUM 56 15 58 96
PLAVIX 56 45 58 42
ALENDRONATE SODIUM 55 43 60 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 13, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.